News

A research team at Mount Sinai have developed a risk score they found accurate in predicting Crohn’s disease in patients ...
Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...
The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory ...
The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...
The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...
The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal ...
Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...
The Global Alzheimer's Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose ...
A blood test that detects early signs of Alzheimer's could be on the NHS in 5 years but with a lack of treatments, would you want to know?
Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...
Biden's aides released new details about his diagnosis amid skepticism that the disease could have progressed to an advanced stage without being detected.
Stage four prostate cancer is a 10 on the Gleason scale, which measures the severity of the disease, with 6 being the lowest ...